Published in Gene Therapy Weekly, February 3rd, 2011
"One of the potential molecular targets is a cancer-specific splicing variant. We have previously shown...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.